Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884873PMC
http://dx.doi.org/10.1111/j.1365-2125.2005.02426.xDOI Listing

Publication Analysis

Top Keywords

introduction tripartite
4
tripartite meeting
4
meeting report
4
report convenors
4
convenors nigel
4
nigel baber
4
baber prof
4
prof ros
4
ros smyth
4
smyth establishing
4

Similar Publications

Dihydroartemisinin ameliorates skeletal muscle atrophy in the lung cancer cachexia mouse model.

J Cancer Res Ther

December 2024

Department of Medical Ultrasound, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong, People's Republic of China.

Introduction: Cancer cachexia (CC) is characterized by weight loss with specifically reduced skeletal muscles and adipose tissues in patients with late-stage cancer. Dihydroartemisinin (DHA), an effective antimalarial derivative of artemisinin, has been demonstrated to have anti-inflammatory and antitumor properties.

Materials And Methods: This study examined the effects of DHA on the Lewis lung carcinoma (LLC)-induced CC mouse model.

View Article and Find Full Text PDF

Decontamination Validation of the BSL-4 Chemical Disinfectant Deluge Shower System.

Appl Biosaf

December 2024

National Microbiology, Public Health Agency of Canada, Winnipeg, Canada.

Introduction: Positive pressure breathing-air-fed protective suits are used in biosafety level 4 (BSL-4) containment laboratories as personal protective equipment to protect workers from high-consequence pathogens. However, even with the use of primary containment devices, the exterior surfaces of these suits could potentially become contaminated with those pathogens and result in their inadvertent removal from containment. To address the risk of such pathogens escaping from containment via contaminated protective suits, these suits are decontaminated in a disinfectant chemical shower situated in an anteroom prior to exiting the BSL-4 laboratory.

View Article and Find Full Text PDF

Introduction: Functional neurological disorder (FND) and autism spectrum disorder (ASD) are two complex neuropsychiatric conditions that have been historically classified within psychiatric domains, resulting in a lack of extensive research, insufficient clinical recognition, and persistent societal stigma. In recent years, there has been an increasing recognition among professionals and affected individuals of their possible overlap. This review explores the potential clinical and mechanistic overlap between FND and ASD, with particular attention to shared symptoms across sensory, motor, and psychiatric domains.

View Article and Find Full Text PDF

Introduction: This work aimed to evaluate the safety and efficacy of hydroxypropyl guar-hyaluronic acid (HPG-HA) dual-polymer lubricating drops in Indian subjects with dry eye disease (DED).

Methods: This prospective, open-label, single-arm, phase IV study was conducted in India.

Inclusion Criteria: Adults (18-65 years) with an average total ocular surface staining (TOSS) score ≥ 4, best-corrected visual acuity of ≥ 20/40 in each eye, tear break-up time (TBUT) ≤ 10 s, and dry eye questionnaire (DEQ-5) score ≥ 6.

View Article and Find Full Text PDF

Utility of Loneliness Status to Risk Stratification and Prediction of Recurrent Atrial Fibrillation After Catheter Ablation.

Adv Ther

November 2024

Department of Cardiology, The Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, Chengdu Cardiovascular Disease Research Institute, Chengdu, 610014, Sichuan, China.

Introduction: Socioeconomic determinants are increasingly important factors in the integrated management of atrial fibrillation (AF). The impact of loneliness status on AF recurrence remains unclear.

Methods: We conducted a cohort study based on patients with AF undergoing catheter ablation from 2017 to 2022.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!